1. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro;Palmer;Arch Int Pharmacodyn Ther,1992
2. Progress report on new antiepileptic drugs;Bialer;Epilepsy Res,1996
3. Remacemide hydrochloride (300mg, 600mg, 800 mg/day) efficacy and safety versus placebo in patients with refractory epilepsy;Jones;Epilepsia,1996
4. Mutual pharmacokinetic interactions between remacemide and carbamazepine and phenytoin but not sodium valproate in epileptic patients;Leach;Epilepsia,1994
5. International classification of epileptic seizures;Epilepsia,1981